HealthEquity vs Humana
Humana reported revenue of $129.7 billion in fiscal 2025, 98.7 times HealthEquity's $1.3 billion in fiscal 2026. HealthEquity's revenue grew 9.5% in its latest year, and Humana's grew 10.1%. HealthEquity had an operating margin of 24.6%, against 2.1% at Humana. Free cash flow was $455 million at HealthEquity and $375 million at Humana. Their fiscal years end in different months (January 31 and December 31), so the periods don't line up exactly.
Side by side
| HealthEquity | Humana | |
|---|---|---|
| Latest fiscal year | FY2026, Jan 31, 2026 | FY2025, Dec 31, 2025 |
| Revenue | $1.3B | $129.7B |
| Revenue growth | 9.5% | 10.1% |
| Revenue growth a year, last 5 years | 12.4% | 10.9% |
| Gross margin | 69.5% | — |
| Operating margin | 24.6% | 2.1% |
| Net margin | 16.4% | 0.9% |
| Free cash flow | $455M | $375M |
| Free cash flow margin | 34.6% | 0.3% |
| Return on capital | 8.9% | 25.7% |
| Net debt to EBITDA | 1.3x | −2.2x |
| Dividends and buybacks | $299M | $581M |
| Change in diluted share count | −1.5% | −0.0% |
| Last close | $103.75 | $417.22 |
| P/E at the last close | 37.5× | 44.5× |
| Insider trades, last 12 months | bought $11,942, sold $4.2 million | bought $150,020, sold $0 |
| Piotroski F-score | 9 of 9 | 5 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
HealthEquityHumana
Operating margin
Percent of revenue
HealthEquityHumana
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
HealthEquityHumana
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the HealthEquity and Humana pages.